Insider · CIK 0001968254
David Krempa
Files at ETON (Eton Pharmaceuticals, Inc.). First filing Jun 16, 2025, latest Oct 6, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ETON: Eton Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 13Weak | ETONsell Eton Pharmaceuticals, Inc. | $229k 4,166 shares | -9% | +282% from low-15% from high | |
| 41Moderate | Eton Pharmaceuticals, Inc. | $504k 34,000 shares | -5% | +203% from low-28% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | ETON Eton Pharmaceuticals, Inc. | MOption exercise Common Stock | +10,522 | - | - | 47,547 | 6 d ago |
| Oct 6, 2026 | ETON Eton Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -4,166 | $55.07 | $229k | 43,381 | 6 d ago |
| Oct 2, 2026 | ETON Eton Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitsderivative | -10,522 | $0.00 | $0 | 21,044 | 6 d ago |
| Jan 14, 2026 | ETON Eton Pharmaceuticals, Inc. | FTax withholding Common Stock | -1,942 | $15.62 | $30k | 630,238 | Jan 14, 2026 |
| Jan 12, 2026 | ETON Eton Pharmaceuticals, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +40,655 | $0.00 | $0 | 670,893 | Jan 14, 2026 |
| Jan 12, 2026 | ETON Eton Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +25,856 | $0.00 | $0 | 696,749 | Jan 14, 2026 |
| Dec 12, 2025 | ETON Eton Pharmaceuticals, Inc. | FTax withholding Common Stock | -6,264 | $17.00 | $106k | 632,180 | Dec 12, 2025 |
| Dec 11, 2025 | ETON Eton Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +5,300 | $0.00 | $0 | 638,468 | Dec 12, 2025 |
| Jun 12, 2025 | ETON Eton Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -16,977 | $14.92 | $253k | 629,669 | Jun 16, 2025 |
| Jun 13, 2025 | ETON Eton Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -6,800 | $14.77 | $100k | 622,869 | Jun 16, 2025 |
| Jun 16, 2025 | ETON Eton Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -10,223 | $14.73 | $151k | 612,646 | Jun 16, 2025 |
| Jan 3, 2025 | ETON Eton Pharmaceuticals, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +38,621 | $0.00 | $0 | 38,621 | Jan 6, 2025 |
| Jan 3, 2025 | ETON Eton Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +25,876 | $0.00 | $0 | 25,876 | Jan 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.